Advances in Lymphoma Research

Advances in Lymphoma Research

AngličtinaPevná vazbaTisk na objednávku
Springer
EAN: 9780792339298
Tisk na objednávku
Předpokládané dodání ve středu, 15. května 2024
5 266 Kč
Běžná cena: 5 851 Kč
Sleva 10 %
ks
Chcete tento titul ještě dnes?
knihkupectví Megabooks Praha Korunní
není dostupné
Librairie Francophone Praha Štěpánská
není dostupné
knihkupectví Megabooks Ostrava
není dostupné
knihkupectví Megabooks Olomouc
není dostupné
knihkupectví Megabooks Plzeň
není dostupné
knihkupectví Megabooks Brno
není dostupné
knihkupectví Megabooks Hradec Králové
není dostupné
knihkupectví Megabooks České Budějovice
není dostupné

Podrobné informace

Fernando Cabanillas In 1993, Fisher et al. published the results of a randomized trial comparing three third-generation regimens against the classic CHOP combination. For several years, the oncology community had been convinced that the third­ generation regimens were clearly superior to CHOP. It came as a shock to many that there was no difference in outcome between the four arms of this clinical trial. The logical conclusion is that CHOP is as good as any of the other regimens tested in that study. Unfortunately, this excellent study has been misinterpreted by many as proving that there has not been any progress in the field of lymphoma during the last 20 years. Furthermore, it has led to a fatalistic attitude in the reasoning of many clinicians who feel that 'nothing works better than CHOP' and therefore that it is not worth testing new drugs or developing novel regimens. However, the process by which we move forward in the oncology field is seldom by dramatic breakthroughs. Frequently, what appears at first glance to be a breakthrough turns out later to be just a modest step forward. Several steps forward eventually add up to a major advance, but this advance goes unnoticed because of the slow nature of the process. In this volume, we have chosen to discuss several of these steps, which we feel are clearly making a positive impact on the field of lymphomas and which soon should make a major difference in therapeutic results.
EAN 9780792339298
ISBN 0792339290
Typ produktu Pevná vazba
Vydavatel Springer
Datum vydání 28. února 1997
Stránky 169
Jazyk English
Rozměry 235 x 155
Země Netherlands
Sekce Professional & Scholarly
Ilustrace XI, 169 p.
Editoři Cabanillas Fernando; Rodriguez M. Alma
Edice 1996 ed.
Série Cancer Treatment and Research